Literature DB >> 4118016

Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.

J B Robbins, L Myerowitz, J K Whisnant, M Argaman, R Schneerson, Z T Handzel, E C Gotschlich.   

Abstract

Enteric bacteria of 1,335 individual strains were studied for serological cross-reactions with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and III. Enterobacterial antigens cross-reactive with the capsular polysaccharides of these four bacteria were found. Bacteria cross-reactive with noncapsular antigens of meningococci and pneumococci were also observed. Since some enteric bacteria possess antigens with serological specificities similar to those of meningococci, the possibility that enteric bacteria cross-reactive with meningococcal antigens provide an antigenic stimulus for the observed age-related "natural" immunity to this pathogen is discussed.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4118016      PMCID： PMC422589          DOI： 10.1128/iai.6.5.651-656.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  CHANGING SUSCEPTIBILITY OF MENINGOCOCCI TO ANTIMICROBIAL AGENTS.

Authors:  T C EICKHOFF; M FINLAND
Journal:  N Engl J Med       Date:  1965-02-25       Impact factor: 91.245

2.  In vitro susceptibility of meningococci to eleven antibiotics and sulfadiazine.

Authors:  B D LOVE; M FINLAND
Journal:  Am J Med Sci       Date:  1954-11       Impact factor: 2.378

3.  Relations between structures of three K polysaccharides of Escherichia coli and cross-reactivity in antipneumococcal sera.

Authors:  M Heidelberger; K Jann; B Jann; F Orskov; I Orskov; O Westphal
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

4.  Prevalence of meningococcal serogroups and description of three new groups.

Authors:  J R Evans; M S Artenstein; D H Hunter
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

5.  Antigenic relationship between Escherichia coli and Neisseria meningitidis.

Authors:  O Grados; W H Ewing
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

6.  The problem of sulfadiazine-resistant meningococci.

Authors:  J M Leedom; D Ivler; A W Mathies; L D Thrupp; J C Fremont; P F Wehrle; B Portnoy
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

7.  Three IgA myeloma immunoglobulins from the BALB/ mouse: precipitation with pneumococcal C polysaccharide.

Authors:  M Potter; M A Leon
Journal:  Science       Date:  1968-10-18       Impact factor: 47.728

8.  Age-related susceptibility to Haemophilus influenzae type b disease in rabbits.

Authors:  R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

9.  An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.

Authors:  R Schneerson; M Bradshaw; J K Whisnant; R L Myerowitz; J C Parke; J B Robbins
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  39 in total

1.  Meningococcal group C conjugate vaccines.

Authors:  J Maclennan
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

2.  Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.

Authors:  Helen Findlow; Jo Southern; Lesley Mabey; Paul Balmer; Robert S Heyderman; Cressida Auckland; Rhonwen Morris; Elizabeth Miller; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

Authors:  Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

Review 5.  Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: Myth or reality?

Authors:  Aylana Reiss-Mandel; Gili Regev-Yochay
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

6.  Practical considerations in using counterimmunoelectrophoresis to identify the principal causative agents of bacterial meningitis.

Authors:  C A Finch; H W Wilkinson
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

7.  Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.

Authors:  K L Seib; D Serruto; F Oriente; I Delany; J Adu-Bobie; D Veggi; B Aricò; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

8.  Pneumococcal antibody levels in patients with acute lung infiltrates.

Authors:  A Löwenberg; J A Snijder; L T vd Weele; H J Sluiter
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

9.  Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.

Authors:  S A Morse; P Vaughan; D Johnson; B H Iglewski
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

10.  Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.

Authors:  G K Schoolnik; T M Buchanan; K K Holmes
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.